###begin article-title 0
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 54 64 <span type="species:ncbi:9598">chimpanzee</span>
Comparative analysis of cancer genes in the human and chimpanzee genomes
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 184 194 <span type="species:ncbi:9598">chimpanzee</span>
###xml 277 287 <span type="species:ncbi:9598">chimpanzee</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
Cancer is a major medical problem in modern societies. However, the incidence of this disease in non-human primates is very low. To study whether genetic differences between human and chimpanzee could contribute to their distinct cancer susceptibility, we have examined in the chimpanzee genome the orthologous genes of a set of 333 human cancer genes.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 569 575 569 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 678 683 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBR2 </italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 79 89 <span type="species:ncbi:9598">chimpanzee</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 320 330 <span type="species:ncbi:9598">chimpanzee</span>
###xml 420 426 <span type="species:ncbi:9606">humans</span>
###xml 614 624 <span type="species:ncbi:9598">chimpanzee</span>
This analysis has revealed that all examined human cancer genes are present in chimpanzee, contain intact open reading frames and show a high degree of conservation between both species. However, detailed analysis of this set of genes has shown some differences in genes of special relevance for human cancer. Thus, the chimpanzee gene encoding p53 contains a Pro residue at codon 72, while this codon is polymorphic in humans and can code for Arg or Pro, generating isoforms with different ability to induce apoptosis or interact with p73. Moreover, sequencing of the BRCA1 gene has shown an 8 Kb deletion in the chimpanzee sequence that prematurely truncates the co-regulated NBR2 gene.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 176 186 <span type="species:ncbi:9598">chimpanzee</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
These data suggest that small differences in cancer genes, as those found in tumor suppressor genes, might influence the differences in cancer susceptibility between human and chimpanzee. Nevertheless, further analysis will be required to determine the exact contribution of the genetic changes identified in this study to the different cancer incidence in non-human primates.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 874 875 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1208 1209 1208 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1357 1359 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1485 1487 1485 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
Cancer is a major and growing clinical problem in modern societies. Although usually referred to as a single disease, cancer represents more than 200 different pathologies, which are characterized by an uncontrolled cell growth that may derive in the invasion of surrounding tissues and the subsequent generation of metastasis in distant organs of the body [1,2]. Tumor development is a complex process in which genetic, epigenetic and environmental factors are implicated [3-6]. The importance of genetic factors in cancer is now well established, as mutations in specific genes have been associated with the neoplastic transformation and development of specific cancer types [3,7,8]. This fact is further supported by the existence of hereditary cancer syndromes, caused by germ-line mutations in specific genes and responsible for about 5% of all diagnosed malignancies [9-11]. Over the last two decades, a number of studies have focused on the identification of the different genes that can contribute to cancer. These studies have led to the conclusion that alterations in three types of genes - oncogenes, tumor-suppressor genes, and stability genes - are mainly associated with the genesis of cancer [3]. These studies have alsocontributed to elucidate the molecular mechanisms through which these genes act during tumor development and progression [12]. Finally, in some cases this knowledge has resulted in the introduction of new therapeutic strategies for cancer treatment [13-16].
###end p 9
###begin p 10
###xml 13 28 13 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes</italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 0 11 <span type="species:ncbi:9598">Chimpanzees</span>
###xml 13 28 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 194 204 <span type="species:ncbi:9598">chimpanzee</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 580 584 <span type="species:ncbi:4456">apes</span>
###xml 653 658 <span type="species:ncbi:9606">human</span>
###xml 663 674 <span type="species:ncbi:9598">chimpanzees</span>
###xml 871 877 <span type="species:ncbi:9606">humans</span>
Chimpanzees (Pan troglodytes) represent our most closely related organism. They have a more similar physiology to human than any other model organism, and the study of several human diseases in chimpanzee has led to a better understanding of pathologies such as hepatitis or AIDS [17,18]. Interestingly, a number of works have reported that cancer incidence in non-human primates is very low. This fact is especially evident for epithelial neoplasms such as breast, prostate or lung carcinomas, which are responsible for more than 20% of human deaths but whose incidence in great apes is less than 2% [18-22]. The difference in cancer incidence between human and chimpanzees can mainly derive from three facts: i) exposure to different environmental factors, including diet and habits, ii) differences in life expectancy and iii) genetic differences that might result in humans being more susceptible to cancer development.
###end p 10
###begin p 11
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 41 51 <span type="species:ncbi:9598">chimpanzee</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 150 160 <span type="species:ncbi:9598">chimpanzee</span>
###xml 301 311 <span type="species:ncbi:9598">chimpanzee</span>
###xml 390 395 <span type="species:ncbi:9606">human</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 551 561 <span type="species:ncbi:9598">chimpanzee</span>
The completion of the first draft of the chimpanzee genome sequence has opened the possibility to study whether genetic differences between human and chimpanzee could contribute to the observed differences in cancer susceptibility between both species [23]. To address this question, we have used the chimpanzee genome sequence to identify and compare the orthologous genes of a set of 333 human genes that have been previously implicated in cancer development [3,7]. This analysis has revealed that all analyzed human cancer genes are present in the chimpanzee and exhibit a high degree of conservation between both species.
###end p 11
###begin p 12
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 168 178 <span type="species:ncbi:9598">chimpanzee</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
###xml 422 432 <span type="species:ncbi:9598">chimpanzee</span>
However, further detailed analysis of a series of genes of special interest in human cancer such as p53 and BRCA1, has revealed some differences with the corresponding chimpanzee counterparts. In this work, we present the results of this comparative genomic analysis and discuss the putative relevance of the observed genetic changes for explaining some aspects of the differential cancer susceptibility between human and chimpanzee.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 32 42 <span type="species:ncbi:9598">chimpanzee</span>
Analysis of cancer genes in the chimpanzee genome
###end title 14
###begin p 15
###xml 194 216 194 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional data file 1</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 62 72 <span type="species:ncbi:9598">chimpanzee</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 121 131 <span type="species:ncbi:9598">chimpanzee</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
As an initial attempt to study cancer-associated genes in the chimpanzee, we have compared 333 human cancer genes to the chimpanzee genome and identified and analyzed the orthologous genes (see Additional data file 1). The set of human cancer genes was selected from the literature based on mutational analysis and/or roles in processes such as chromosomal stability, promoter methylation or control of mitotic checkpoints [3,4,7,24-28]. As can be seen in Figure 1, more than 50% of the genes belong to three main functional categories: transcription factors, phosphorylation (including kinases, kinase inhibitors and phosphatases), and DNA repair. Other functional groups include structural proteins, GTPases and GTPase regulators or proteins involved in ubiquitylation. Finally, other minor groups include tumor suppressors, the protein and RNA components of the telomerase, or proteins implicated in apoptosis among others.
###end p 15
###begin p 16
###xml 593 615 593 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional data file 1</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 97 107 <span type="species:ncbi:9598">chimpanzee</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 323 333 <span type="species:ncbi:9598">chimpanzee</span>
To perform this study, the cDNA sequence from all human cancer genes was first compared with the chimpanzee genome in order to determine the presence or absence of the corresponding orthologs, and then to predict their complete cDNA sequences. This analysis revealed that all analyzed human cancer genes are present in the chimpanzee genome. The high sequence coverage of this set of cancer genes (96% coverage at the nucleotide level, 1,161,044 nucleotides), has allowed us to perform a detailed comparison - at the nucleotide and amino acid level - of cancer genes between both species (see Additional data file 1 for more details).
###end p 16
###begin p 17
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 426 448 426 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">Additional data file 2</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 882 883 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 31 41 <span type="species:ncbi:9598">chimpanzee</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 502 512 <span type="species:ncbi:9598">chimpanzee</span>
###xml 744 749 <span type="species:ncbi:4932">yeast</span>
###xml 753 758 <span type="species:ncbi:9606">human</span>
Direct comparison of human and chimpanzee cancer genes indicates that they are highly conserved, showing 99.38% identities at the protein level, and 99.19% at the nucleotide level, what is similar to the average amino acid identities between both organisms (99.38%) [23]. Interestingly, we have identified 71 cancer genes (representing 21% of the total) encoding proteins which are 100% identical to their human counterparts (Additional data file 2). The conservation of cancer genes between human and chimpanzee suggests that they perform essential cellular functions and are in agreement with previous studies [29]. This proposal is consistent with the fact that most analyzed cancer genes encode intracellular proteins highly conserved from yeast to human, and implicated in fundamental processes such as cell signalling, cell cycle control and maintenance of genomic stability [3].
###end p 17
###begin title 18
Analysis of insertions and deletions in protein coding regions from thechimpanzee genome
###end title 18
###begin p 19
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 695 698 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MN1</italic>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1190 1197 1190 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASPSCR1</italic>
###xml 1199 1202 1199 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEK</italic>
###xml 1204 1209 1204 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FANCC</italic>
###xml 1211 1216 1211 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLLT3</italic>
###xml 1218 1224 1218 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYST4 </italic>
###xml 1228 1234 1228 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZNF384</italic>
###xml 1382 1384 1382 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 48 58 <span type="species:ncbi:9598">chimpanzee</span>
###xml 141 151 <span type="species:ncbi:9598">chimpanzee</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 468 478 <span type="species:ncbi:9598">chimpanzee</span>
###xml 630 640 <span type="species:ncbi:9598">chimpanzee</span>
###xml 722 732 <span type="species:ncbi:9598">chimpanzee</span>
###xml 788 793 <span type="species:ncbi:9606">human</span>
###xml 846 856 <span type="species:ncbi:9598">chimpanzee</span>
###xml 884 889 <span type="species:ncbi:9606">human</span>
###xml 981 987 <span type="species:ncbi:9606">humans</span>
###xml 996 1006 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1177 1182 <span type="species:ncbi:9606">human</span>
###xml 1324 1330 <span type="species:ncbi:9606">humans</span>
###xml 1370 1380 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1605 1610 <span type="species:ncbi:9606">human</span>
###xml 1611 1621 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1678 1684 <span type="species:ncbi:9606">humans</span>
Despite the high conservation between human and chimpanzee cancer genes described above, in the course of the present study we identified 20 chimpanzee genes (6% of all analyzed genes) that encode proteins containing or lacking specific residues due to the insertion or deletion of codons in the corresponding open reading frames (Table 1). The analysis of these genes can be important in order to identify human-specific changes in protein coding genes. A total of 9 chimpanzee genes encode proteins containing extra amino acids in their sequence, 6 of them located within trinucleotide repeats resulting in longer expansions in chimpanzee, with up to 4 extra glutamine residues in the case of MN1. On the other hand, 12 chimpanzee genes encode proteins with less amino acids than their human counterparts. Similarly to the expanded proteins in chimpanzee, 8 of the 12 expansions in human proteins were located in trinucleotide repeats. The higher proportion of longer alleles in humans than in chimpanzee is consistent with known results [30]. Interestingly, analysis of these expanded regions using information retrieved from EST databases, resulted in the finding that six human genes, ASPSCR1, DEK, FANCC, MLLT3, MYST4 and ZNF384, are polymorphic for these loci. As functional trinucleotide tandem repeats that vary in humans have been shown to be also variable in chimpanzee [30], it is likely that all these genes present variability in both species. These results suggest that these regions might be prone to genetic instability, and open the possibility to investigate if all these genes showing human-chimpanzee variability in trinucleotide repeats are polymorphic in humans and influence the risk of tumor development.
###end p 19
###begin p 20
###xml 202 224 202 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">Additional data file 3</xref>
###xml 292 302 292 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 770 778 770 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 1301 1305 1301 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BCL3</italic>
###xml 1307 1310 1307 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ELL</italic>
###xml 1312 1316 1312 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAS7</italic>
###xml 1318 1321 1318 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLL</italic>
###xml 1323 1328 1323 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLLT3</italic>
###xml 1330 1333 1330 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NF1</italic>
###xml 1335 1341 1335 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RECQL4</italic>
###xml 1343 1351 1343 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMARCB1 </italic>
###xml 1355 1358 1355 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TPR</italic>
###xml 532 542 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1477 1482 <span type="species:ncbi:9606">human</span>
###xml 1487 1497 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1847 1857 <span type="species:ncbi:9598">chimpanzee</span>
During the course of this analysis, we also observed that 52 genes (representing 15.6% of all analyzed cancer genes) contained putative frameshifts and/or premature stop codons in the coding sequences (Additional data file 3). This high number of conflictive regions is not likely to reflect bona fide differences between these species, but the result of sequencing problems or artefacts derived from the assembly process. To evaluate these possibilities, we took advantage of the availability of two independent assemblies for the chimpanzee genome, called ARACHNE and PCAP [23]. The ARACHNE assembly, containing more coverage and fewer order conflicts, is used by most public genome browsers and was employed in the initial steps of this study. The PCAP assembly is a de novo assembly that is non-redundant with ARACHNE and provides an additional resource for this kind of sequencing conflicts. To distinguish artefacts of the assembly process from real differences or sequencing errors, we compared the conflictive regions identified in cancer genes to the PCAP assembly. This strategy resulted in the resolution of 83% of the conflicts, as they were correct in the PCAP assembly, thereby suggesting that they represented errors generated during the assembly process. Nevertheless, 9 cancer genes (BCL3, ELL, GAS7, MLL, MLLT3, NF1, RECQL4, SMARCB1 and TPR) still contained the same frameshift in both assemblies. Because these genes might represent real differences between human and chimpanzee cancer genes, we PCR-amplified all these conflictive regions, and the resulting DNA fragments were subjected to direct sequencing. This strategy allowed us to confirm that these genes do not contain frameshifts or premature stop codons, and encode functional proteins in all cases. These findings call the attention to the degree of accuracy of the chimpanzee genome despite the existence of two assemblies. Ongoing efforts to increase the shotgun coverage from ~4 fold to ~8 fold redundancy will produce a higher quality sequence necessary for a reliable ascertainment of specific interesting discrepancies.
###end p 20
###begin title 21
###xml 54 64 <span type="species:ncbi:9598">chimpanzee</span>
Analysis of missense mutations in cancer genes in the chimpanzee genome
###end title 21
###begin p 22
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 926 932 926 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2 </italic>
###xml 936 941 936 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERBB2</italic>
###xml 1079 1085 1079 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2 </italic>
###xml 1097 1103 1097 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERBB2 </italic>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1418 1420 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 354 364 <span type="species:ncbi:9598">chimpanzee</span>
###xml 517 527 <span type="species:ncbi:9598">chimpanzee</span>
###xml 568 573 <span type="species:ncbi:9606">human</span>
###xml 681 686 <span type="species:ncbi:9606">human</span>
###xml 702 707 <span type="species:ncbi:9606">Human</span>
###xml 778 781 <span type="species:ncbi:9606">Man</span>
###xml 783 787 <span type="species:ncbi:9606">OMIM</span>
###xml 856 866 <span type="species:ncbi:9598">chimpanzee</span>
###xml 956 966 <span type="species:ncbi:9598">chimpanzee</span>
###xml 994 999 <span type="species:ncbi:9606">human</span>
###xml 1057 1063 <span type="species:ncbi:9606">humans</span>
###xml 1223 1233 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1389 1395 <span type="species:ncbi:9606">humans</span>
Mutations in human cancer genes can be originated by different causes, including chromosomal translocations resulting in fusion proteins, disruption of the coding sequence by frameshifts or premature stop codons, and point mutations that modify the structure and function of the corresponding protein. As mentioned above, we did not find evidence in the chimpanzee genome of gene fusions, frameshifts or premature stop codons in the set of analyzed cancer genes. However, it is interesting to study the status in the chimpanzee genome of residues that are variable in human genes and are associated with cancer. For this purpose, we extracted the information of variant alleles in human genes from the Human Gene Mutation Database (HGMD) and the Online Mendelian Inheritance in Man (OMIM) databases [31,32], and determined the corresponding residue in the chimpanzee protein. We found two genes associated with breast cancer, BRCA2 and ERBB2, in which the chimpanzee sequence differed from the human in residues that have been reported to be polymorphic in humans. Both alleles, BRCA2 (N372H) and ERBB2 (V655I), have been associated with different risk of developing breast cancer [33,34]. Interestingly, in both cases the chimpanzee sequence (N372 and I655) corresponds to the allele that has been associated with a reduced risk of cancer, and both are being found at high frequencies in humans, around 0.8 for N372 [34] and from 0.7 to 0.9 for I665.
###end p 22
###begin p 23
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1 </italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2 </italic>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 242 252 <span type="species:ncbi:9598">chimpanzee</span>
We also identified at least two cases in genes associated with colon carcinomas, MLH1 (A441T) and MSH2 (S323C), and one with prostate carcinomas, PON1 (I102V), in which the susceptibility allele in human appears to be the wild-type allele in chimpanzee. However, due to the limited clinical and functional data on these variants, the biological significance of these findings is still unknown, and further studies will be required to determine the pathogenic activity of these alleles.
###end p 23
###begin title 24
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 49 59 <span type="species:ncbi:9598">chimpanzee</span>
Analysis of the tumor suppressor gene p53 in the chimpanzee genome
###end title 24
###begin p 25
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 208 218 <span type="species:ncbi:9598">chimpanzee</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 362 372 <span type="species:ncbi:9598">chimpanzee</span>
###xml 496 506 <span type="species:ncbi:9598">chimpanzee</span>
###xml 609 619 <span type="species:ncbi:9598">chimpanzee</span>
###xml 780 790 <span type="species:ncbi:9598">chimpanzee</span>
###xml 888 898 <span type="species:ncbi:9598">chimpanzee</span>
A detailed analysis of the gene encoding the tumor suppressor p53, which is the most frequently mutated gene in human cancer [35], showed a single amino acid difference between human (Arg at position 72) and chimpanzee (Pro72). Interestingly, this p53 codon is polymorphic in human and the allele encoding Pro72 is frequent in some populations [36]. Analysis of chimpanzee DNA from four different geographic regions revealed a Pro/Pro genotype in all cases, what confirmed our findings using the chimpanzee genomic sequence. However, we cannot rule out the possibility that this codon might be polymorphic in chimpanzee and that the Arg72 allele could be present in some individuals, what would require the analysis of a greater number of samples. In this sense, sequencing of 14 chimpanzee samples revealed a Pro/Pro genotype, suggesting that this allele would be the most common one in chimpanzee, with a Poisson distribution maximum estimate of allele frequency of 0.1 at a 95% confidence interval.
###end p 25
###begin p 26
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 85 92 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 94 103 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 107 115 <span type="species:ncbi:9561">mandrill</span>
###xml 199 203 <span type="species:ncbi:4456">apes</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 420 426 <span type="species:ncbi:9606">humans</span>
Additionally, we have sequenced the same p53 region in different primates, including gorilla, orangutan or mandrill, and determined that codon 72 codes for Pro in all species (Fig. 2). The fact that apes and some Old World monkeys contain Pro at this position, suggests that it is the ancestral allele and the Arg72 allele is unique to the human lineage. Nevertheless, the ancestral Pro/Pro genotype is still present in humans, representing about 8.3% of the Central-European population and 45% of the African yoruba population (see dbSNP rs1042522) [37]. This finding raises interesting questions about the different susceptibility to cancer of both organisms, as several studies have shown that both isoforms are functionally different in their ability to induce apoptosis or interact with p73 [38-40].
###end p 26
###begin title 27
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 35 45 <span type="species:ncbi:9598">chimpanzee</span>
Analysis of the BRCA1 locus in the chimpanzee genome
###end title 27
###begin p 28
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 443 449 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 697 703 697 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBR2</italic>
###xml 733 739 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 763 773 763 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBR1/M17S2</italic>
###xml 858 864 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 938 944 938 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 1161 1166 1161 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBR2 </italic>
###xml 1192 1198 1192 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 1374 1380 1374 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1 </italic>
###xml 1384 1389 1384 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nbr1 </italic>
###xml 1390 1392 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 183 193 <span type="species:ncbi:9598">chimpanzee</span>
###xml 401 406 <span type="species:ncbi:9606">human</span>
###xml 411 421 <span type="species:ncbi:9598">chimpanzee</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 492 502 <span type="species:ncbi:9598">chimpanzee</span>
###xml 820 825 <span type="species:ncbi:9606">human</span>
###xml 830 840 <span type="species:ncbi:9598">chimpanzee</span>
###xml 986 992 <span type="species:ncbi:9606">humans</span>
###xml 997 1007 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1115 1125 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1212 1222 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1294 1299 <span type="species:ncbi:10090">mouse</span>
The tumor suppressor BRCA1 has an unusual evolutionary history, in that ratios of replacement to silent nucleotide substitutions (KA/KS) are greater than one when comparing human and chimpanzee lineages, but not in lineages of other primates or other mammals [41-43]. This observation is consistent with positive selection pressure on BRCA1 during recent hominoid evolution. We evaluated the complete human and chimpanzee genomic sequences of BRCA1 in light of this observation. In human and chimpanzee, the BRCA1 locus spans ~130 kb, including the BRCA1 gene itself and a partially duplicated 5' (telomeric) region. The duplication includes the highly conserved bidirectional promoter regulating BRCA1 and the adjacent gene NBR2, a BRCA1 partial pseudogene, and NBR1/M17S2. The number of nucleotide differences between human and chimpanzee sequences at the BRCA1 locus is not remarkable, 1.15%, and does not vary appreciably between the BRCA1 locus and the duplicated region. However, humans and chimpanzee sequences differ by an 8 Kb insertion/deletion within the partially duplicated region. The deletion on the chimpanzee sequence prematurely truncates the NBR2 gene. The consequences to BRCA1 expression in chimpanzee of the truncation of the adjacent, co-regulated gene are not known. In mouse, the region is not duplicated and the bidirectional promoter co-regulates Brca1 and Nbr1 [44].
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1492 1494 1492 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 24 34 <span type="species:ncbi:9598">chimpanzee</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 327 333 <span type="species:ncbi:9606">humans</span>
###xml 480 486 <span type="species:ncbi:9606">humans</span>
###xml 491 502 <span type="species:ncbi:9598">chimpanzees</span>
###xml 547 557 <span type="species:ncbi:9598">chimpanzee</span>
###xml 581 586 <span type="species:ncbi:9606">human</span>
###xml 688 693 <span type="species:ncbi:9606">human</span>
###xml 739 749 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1080 1085 <span type="species:ncbi:9606">human</span>
###xml 1089 1099 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1194 1199 <span type="species:ncbi:9606">human</span>
###xml 1359 1364 <span type="species:ncbi:9606">human</span>
###xml 1369 1379 <span type="species:ncbi:9598">chimpanzee</span>
The availability of the chimpanzee genome sequence provides an excellent opportunity to explore the genetic basis for some of the biological differences between human and our most closely related organism [23]. An striking finding in this regard is the observation that non-human primates show a lower incidence of cancer than humans, specifically for epithelial carcinomas [18,20]. To investigate if this different susceptibility to cancer was due to genetic differences between humans and chimpanzees, we performed a comparative analysis in the chimpanzee genome of a set of 333 human genes that have been directly implicated in tumor development [3,7]. This analysis revealed that all human cancer genes contain a clear ortholog in the chimpanzee genome, and show a percentage of identities at the protein level similar to the genome average (99.38%). Nevertheless, the strict conservation of this group of more than 330 genes contrasts with the recent analysis of other groups of genes, including a set of 560 proteases, which shows that at least 7 genes are absent in either human or chimpanzee genomes [45], or the CD33-related Siglecs, which also show specific loss of some genes in the human lineage [46]. These data suggest that despite cancer genes show a percentage of identities similar to the genome average, they are perfectly conserved between human and chimpanzee, confirming previous studies showing a higher conservation of genes implicated in essential cellular functions [29].
###end p 30
###begin p 31
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1005 1006 1005 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1088 1089 1088 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1090 1091 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 189 199 <span type="species:ncbi:9598">chimpanzee</span>
###xml 985 990 <span type="species:ncbi:9606">human</span>
###xml 1070 1075 <span type="species:ncbi:9606">human</span>
###xml 1242 1247 <span type="species:ncbi:9606">human</span>
###xml 1252 1262 <span type="species:ncbi:9598">chimpanzee</span>
This study has shown that despite the high degree of identity in cancer genes, there are 1542 amino acid changes whose contribution to the different cancer susceptibility between human and chimpanzee should be further investigated. Nevertheless, additional factors contributing to the observed differences could include changes in diet, lifestyle or exposure to mutagenic agents [47-49]; physiological differences in immune system or in life expectancy and aging rates [50]; variations in gene expression, alternative splicing or in DNA methylation patterns [51,52]; or alterations in other genes not analyzed in this study. In this regard, we must emphasize that we have compiled a group of 333 genes that are causally implicated in cancer development as a result of mutational analysis or owing to their participation in processes such as control of mitotic checkpoints, chromosomal stability or promoter methylation. This set of genes includes those annotated in a recent census of human cancer genes [7], but also incorporates novel genes described to be mutated in human carcinomas [3,4,25-28]. However, the possibility that other yet unknown cancer-related genes are responsible for the different susceptibility to this disease between human and chimpanzee, cannot be ruled out.
###end p 31
###begin p 32
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1286 1288 1286 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1289 1291 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1420 1422 1420 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 529 539 <span type="species:ncbi:9598">chimpanzee</span>
###xml 645 650 <span type="species:ncbi:9606">human</span>
###xml 950 955 <span type="species:ncbi:9606">human</span>
###xml 960 970 <span type="species:ncbi:9598">chimpanzee</span>
In relation to the existence of functional differences in the immune system of human and non-human primates, it is now clear that the immune and inflammatory responses play important roles in cancer development and progression [53-56]. Accordingly, structural and functional variations in genes associated with these processes might be responsible for the species-specific susceptibility to certain tumors. Life expectancy is another factor that might contribute to the observed differences in cancer incidence between human and chimpanzee. Although age is known to represent a major risk factor for cancer development, the observation that non-human primates have a lower incidence of epithelial carcinomas but not other cancers [18], suggests that life expectancy might contribute only partially to the observed differences in cancer susceptibility. On the other hand, and despite the strong conservation in the coding regions of cancer genes from human and chimpanzee, it is possible that differences in regulatory elements outside these coding regions can result in changes in the expression levels or in the tissue distribution patterns [57]. In fact, recent reports have shown considerable differences in the expression levels of orthologous genes from different primate species [58-60], supporting the idea that regulatory changes might account for some interspecies differences, including cancer susceptibility [61].
###end p 32
###begin p 33
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASPSCR1</italic>
###xml 635 638 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEK</italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FANCC</italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLLT3</italic>
###xml 654 660 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYST4 </italic>
###xml 664 670 664 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZNF384</italic>
###xml 511 516 <span type="species:ncbi:9606">human</span>
###xml 521 531 <span type="species:ncbi:9598">chimpanzee</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
Despite the high conservation of cancer genes between both species, we identified 20 genes containing several codon insertions or deletions in their protein coding regions, although the functional significance of these differences, including their putative association with cancer, will require further studies. It is interesting to note that in 70% of these cases, the insertion/deletion event occurred within trinucleotide repeats, suggesting that these regions could be prone to genetic instability, in both human and chimpanzee genomes. Analysis of EST databases allowed us to confirm this hypothesis, as six human genes, ASPSCR1, DEK, FANCC, MLLT3, MYST4 and ZNF384, were polymorphic in the number of repeats in these regions. In the case of genes implicated in cancer, it will also be interesting to study if some of the identified haplotypes could confer a higher risk of tumor development.
###end p 33
###begin p 34
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1430 1432 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1433 1435 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 85 95 <span type="species:ncbi:9598">chimpanzee</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 288 298 <span type="species:ncbi:9598">chimpanzee</span>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 523 528 <span type="species:ncbi:9606">human</span>
###xml 589 594 <span type="species:ncbi:9606">human</span>
###xml 746 751 <span type="species:ncbi:9606">human</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
###xml 817 827 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1125 1145 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 1487 1497 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1563 1568 <span type="species:ncbi:9606">human</span>
The fact that most cancer genes show a high degree of conservation between human and chimpanzee, prompted us to analyze in more detail the observed changes in genes previously reported to be of special relevance in human cancer, such as the tumor suppressors p53 and BRCA1. We found that chimpanzee p53 shows a single amino acid difference with human p53, resulting in a protein containing Pro instead of Arg at position 72. Interestingly, this codon is polymorphic in human, and the Pro72 residue is common in all studied human populations [36,62]. Sequencing of this region in other non-human primates allowed us to confirm that this Pro residue has been conserved during evolution, and suggests that the Arg72 allele, present in 55-92% of the human population, arose in the human lineage. The presence of Pro72 in chimpanzee might have physiological consequences, as several reports have found interesting functional differences between both p53 isoforms. In fact, p53-Arg72 protein has an increased ability to induce apoptosis, to translocate from the nucleus to the mitochondria, to be degraded by the E6 oncoprotein of human papillomavirus or to inactivate p73 when mutated [38-40]. Different studies have provided evidence for an increasedrisk of cancer development associated with the Arg72 genotype, although this topic has been controversial and further studies will be necessary to definitely address this question [39,40,63]. Therefore, and although the presence of Pro72 in chimpanzee p53 might contribute to the reduced cancer susceptibility in non-human primates, further work will be required to confirm this hypothesis.
###end p 34
###begin p 35
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBR2 </italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBR2 </italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 569 575 569 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 718 724 718 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 206 216 <span type="species:ncbi:9598">chimpanzee</span>
###xml 328 338 <span type="species:ncbi:9598">chimpanzee</span>
###xml 589 599 <span type="species:ncbi:9598">chimpanzee</span>
###xml 697 702 <span type="species:ncbi:9606">human</span>
###xml 707 717 <span type="species:ncbi:9598">chimpanzee</span>
Analysis of the tumor suppressor BRCA1 has shown that it has been subjected to positive selection during recent hominoid evolution, as the overall KA/KS ratios are greater than one when comparing human and chimpanzee lineages, but not on lineages of other primates or mammals, as has been recently shown [43]. Additionally, the chimpanzee BRCA1 locus contains an 8 Kb deletion in the partially duplicated 5' region. This deletion prematurely truncates the NBR2 gene, which is regulated by a bi-directional promoter that co-regulates NBR2 and BRCA1. The consequences to BRCA1 expression in chimpanzee of the truncation of the adjacent, co-regulated gene are not known. The distinctive evolution of human and chimpanzee BRCA1 suggest that an evolutionary approach may be important to understanding selection at this, and perhaps other cancer associated genes [43,64,65].
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 471 477 471 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 134 144 <span type="species:ncbi:9598">chimpanzee</span>
###xml 623 628 <span type="species:ncbi:9606">human</span>
###xml 629 639 <span type="species:ncbi:9598">chimpanzee</span>
In summary, in this work we have performed an analysis of a defined set of 333 genes to try to elucidate the molecular basis of human-chimpanzee differences in one aspect of significant biomedical relevance: the interspecies variability in cancer susceptibility. The overall picture emerging from this comparative analysis is one that reflects the high degree of conservation in this group of cancer genes, although specific differences in relevant genes such as p53 and BRCA1 can illuminate new functional and evolutionary aspects of these tumor-suppressor genes. Altogether, the limited genetic variability found in this human-chimpanzee comparative analysis might contribute to the different cancer susceptibility between these closely related species. However, further investigations will be necessary to determine the influence of these genetic changes in cancer, or whether additional factors, such as changes in gene regulation, immune system genes, life expectancy or environmental influences, might also contribute to this process.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
###xml 31 41 <span type="species:ncbi:9598">chimpanzee</span>
Bioinformatic screening of the chimpanzee genome
###end title 39
###begin p 40
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 610 632 610 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional data file 1</xref>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 256 266 <span type="species:ncbi:9598">chimpanzee</span>
###xml 364 374 <span type="species:ncbi:9598">chimpanzee</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 660 670 <span type="species:ncbi:9598">chimpanzee</span>
###xml 757 767 <span type="species:ncbi:9598">Chimpanzee</span>
###xml 892 902 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1034 1044 <span type="species:ncbi:9598">chimpanzee</span>
A database of human cancer genes was constructed by using information from the literature, and the corresponding cDNA and protein sequences were retrieved from the GenBank database. Each single human cDNA sequence was compared against the ARACHNE and PCAP chimpanzee genome assemblies by using a combination of BLAT and BLAST algorithms [66,67]. The corresponding chimpanzee cDNA and protein sequences were extracted and compared to the human ortholog by using the EMBOSS sequence analysis package. The full list of cancer genes, accession numbers and comparison to the human orthologs are available at in the Additional data file 1. In all cases, the primary chimpanzee cDNA sequence was obtained from the ARACHNE assembly, as this sequence is used by the Chimpanzee Genome Sequencing Consortium and by most public genome browsers (NBCI, Ensembl, or UCSC). However, in those cases where the chimpanzee gene was incomplete, the PCAP assembly was used to fill gaps in the genome, and the corresponding sequence was incorporated to the chimpanzee cDNA sequence for our analysis.
###end p 40
###begin p 41
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO2</italic>
###xml 311 321 311 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLLT7, MN1</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYST4</italic>
###xml 97 107 <span type="species:ncbi:9598">chimpanzee</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 403 413 <span type="species:ncbi:9598">chimpanzee</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 541 546 <span type="species:ncbi:9606">human</span>
###xml 614 619 <span type="species:ncbi:9606">human</span>
###xml 723 733 <span type="species:ncbi:9598">chimpanzee</span>
###xml 783 793 <span type="species:ncbi:9598">chimpanzee</span>
###xml 888 898 <span type="species:ncbi:9598">chimpanzee</span>
Conflictive regions were defined as those presenting frameshifts or premature stop codons in the chimpanzee coding sequence. Those regions were carefully examined in both ARACHNE and PCAP assemblies, as well as the corresponding human region in the human genome sequence and EST databases. In four cases (LMO2, MLLT7, MN1, and MYST4) the presence of a putative frameshift or premature stop codon in the chimpanzee sequence resulted from incorrect human sequence entries that contained frameshifts in the deposited entry. Modification of the human cDNA with the aid of EST and genomic sequences resulted in curated human cDNA and protein sequences, and the absence of frameshift or premature stop codon in the corresponding chimpanzee prediction. All other conflictive regions in the chimpanzee genome were solved by PCR amplification and direct sequencing of the corresponding gene using chimpanzee genomic DNA.
###end p 41
###begin title 42
###xml 43 53 <span type="species:ncbi:9598">chimpanzee</span>
PCR amplification and direct sequencing of chimpanzee genes
###end title 42
###begin p 43
###xml 274 296 274 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">Additional data file 3</xref>
###xml 0 10 <span type="species:ncbi:9598">Chimpanzee</span>
###xml 12 19 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 21 30 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 35 43 <span type="species:ncbi:9561">mandrill</span>
###xml 186 196 <span type="species:ncbi:9598">chimpanzee</span>
###xml 351 361 <span type="species:ncbi:9598">chimpanzee</span>
Chimpanzee, gorilla, orangutan and mandrill genomic DNA from different geographic regions was obtained using standard phenol-chloroform procedures. To analyze conflictive regions in the chimpanzee genome, we designed specific oligonucleotides flanking the exon of interest (Additional data file 3), and the corresponding region was PCR amplified from chimpanzee total genomic DNA in a Perkin Elmer 9700 thermocycler using High Fidelity Taq DNA polymerase or GC-RICH PCR system for regions rich in GC content (Roche Diagnostics). The amplified product was purified and subjected to automatic sequencing using the 5' oligonucleotide as primer using an ABI Prism 310 DNA sequencer (Applied Biosystems).
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
###xml 336 342 336 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1 </italic>
XSP conceived this project, participated in the design and bioinformatic analysis, and drafted the manuscript. CLO also conceived this project and participated in the elaboration of the gene census. GV and AGF performed the bioinformatic analysis, gene comparison and PCR amplification and sequencing. MCK performed the analysis of the BRCA1 locus. JB provided DNA samples from different primates and helped with the analysis of p53. All authors read and approved the final manuscript.
###end p 45
###begin title 46
Supplementary Material
###end title 46
###begin title 47
Additional data file 1
###end title 47
###begin p 48
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human and chimpanzee cancer genes comparison</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 20 <span type="species:ncbi:9598">chimpanzee</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 96 106 <span type="species:ncbi:9598">chimpanzee</span>
Human and chimpanzee cancer genes comparison. This file contains the complete list of human and chimpanzee cancer genes, and comparison at the nucleotide and protein level.
###end p 48
###begin p 49
Click here for file
###end p 49
###begin title 50
Additional data file 2
###end title 50
###begin p 51
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chimpanzee cancer gene products identical to human orthologs</bold>
###xml 0 10 <span type="species:ncbi:9598">Chimpanzee</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 95 105 <span type="species:ncbi:9598">chimpanzee</span>
Chimpanzee cancer gene products identical to human orthologs. List of human genes identical to chimpanzee orthologs. Gene name, accession number, chromosomal location, protein length and functional category are indicated.
###end p 51
###begin p 52
Click here for file
###end p 52
###begin title 53
Additional data file 3
###end title 53
###begin p 54
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Frameshifts in chimpanzee cancer genes</bold>
###xml 15 25 <span type="species:ncbi:9598">chimpanzee</span>
###xml 48 58 <span type="species:ncbi:9598">chimpanzee</span>
Frameshifts in chimpanzee cancer genes. List of chimpanzee cancer genes for which frameshifts or premature stop codons are present in the ARACHNE assembly, as well as the correct sequence obtained by direct sequencing or comparison with the PCAP assembly.
###end p 54
###begin p 55
Click here for file
###end p 55
###begin title 56
Acknowledgements
###end title 56
###begin p 57
###xml 363 373 <span type="species:ncbi:9598">chimpanzee</span>
This work has been supported by grants from Comision Interministerial de Ciencia y Tecnologia-Spain; Fundacion la Caixa, European Union (Cancer Degradome-FP6) and Ramon y Cajal Program (XSP). The Instituto Universitario de Oncologia is supported by Obra Social Cajastur-Asturias and Red de Centros de Cancer-Instituto Carlos III, Spain. We thank Dr. W. Enard for chimpanzee DNA samples, and S. Alvarez and P. Martin Bringas for excellent technical assistance. Some samples were provided by the Barcelona Zoo under the agreement of the Primate DNA Bank with the Pompeu Fabra University.
###end p 57
###begin article-title 58
Modelling the molecular circuitry of cancer
###end article-title 58
###begin article-title 59
Dissecting the metastatic cascade
###end article-title 59
###begin article-title 60
Cancer genes and the pathways they control
###end article-title 60
###begin article-title 61
The history of cancer epigenetics
###end article-title 61
###begin article-title 62
###xml 52 58 <span type="species:ncbi:9606">people</span>
Have environmental mutagens caused oncomutations in people?
###end article-title 62
###begin article-title 63
###xml 22 27 <span type="species:ncbi:9606">human</span>
The emerging roles of human tissue kallikreins in cancer
###end article-title 63
###begin article-title 64
###xml 12 17 <span type="species:ncbi:9606">human</span>
A census of human cancer genes
###end article-title 64
###begin article-title 65
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 104 122 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus
###end article-title 65
###begin article-title 66
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
###end article-title 66
###begin article-title 67
Testing guidelines for hereditary non-polyposis colorectal cancer
###end article-title 67
###begin article-title 68
Genetic testing for cancer susceptibility: the promise and the pitfalls
###end article-title 68
###begin article-title 69
The hallmarks of cancer
###end article-title 69
###begin article-title 70
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
###end article-title 70
###begin article-title 71
Targeted therapy in breast cancer: the HER-2/neu gene and protein
###end article-title 71
###begin article-title 72
The proteasome: a suitable antineoplastic target
###end article-title 72
###begin article-title 73
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
###end article-title 73
###begin article-title 74
###xml 4 14 <span type="species:ncbi:9598">chimpanzee</span>
###xml 24 41 <span type="species:ncbi:11103">hepatitis C virus</span>
The chimpanzee model of hepatitis C virus infections
###end article-title 74
###begin article-title 75
###xml 2 12 <span type="species:ncbi:9598">chimpanzee</span>
A chimpanzee genome project is a biomedical imperative
###end article-title 75
###begin article-title 76
###xml 47 51 <span type="species:ncbi:9615">dogs</span>
Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates
###end article-title 76
###begin article-title 77
An overview of the world literature on spontaneous tumors in nonhuman primates
###end article-title 77
###begin article-title 78
Tumors in nonhuman primates: observations during a six-year period in the Yerkes primate center colony
###end article-title 78
###begin article-title 79
Neoplasms and proliferative lesions in 1065 nonhuman primate necropsies
###end article-title 79
###begin article-title 80
###xml 24 34 <span type="species:ncbi:9598">chimpanzee</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Initial sequence of the chimpanzee genome and comparison with the human genome
###end article-title 80
###begin article-title 81
The DNA damage response: putting checkpoints in perspective
###end article-title 81
###begin article-title 82
Connecting chromosomes, crisis, and cancer
###end article-title 82
###begin article-title 83
Inactivation of hCDC4 can cause chromosomal instability
###end article-title 83
###begin article-title 84
Mutational analysis of the tyrosine phosphatome in colorectal cancers
###end article-title 84
###begin article-title 85
Three classes of genes mutated in colorectal cancers with chromosomal instability
###end article-title 85
###begin article-title 86
Evolutionary dynamics of oncogenes and tumor suppressor genes: higher intensities of purifying selection than other genes
###end article-title 86
###begin article-title 87
###xml 67 73 <span type="species:ncbi:9606">humans</span>
###xml 78 82 <span type="species:ncbi:4456">apes</span>
Comparative genetics of functional trinucleotide tandem repeats in humans and apes
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Gene Mutation Database (HGMD): 2003 update
###end article-title 88
###begin article-title 89
###xml 32 35 <span type="species:ncbi:9606">Man</span>
###xml 37 41 <span type="species:ncbi:9606">OMIM</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders
###end article-title 89
###begin article-title 90
Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk
###end article-title 90
###begin article-title 91
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
###end article-title 91
###begin article-title 92
The p53 tumor suppressor gene: from molecular biology to clinical investigation
###end article-title 92
###begin article-title 93
Is p53 polymorphism maintained by natural selection?
###end article-title 93
###begin article-title 94
The International HapMap Project
###end article-title 94
###begin article-title 95
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
###end article-title 95
###begin article-title 96
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
###end article-title 96
###begin article-title 97
###xml 49 69 <span type="species:ncbi:10566">human papillomavirus</span>
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
###end article-title 97
###begin article-title 98
###xml 53 59 <span type="species:ncbi:9606">humans</span>
###xml 64 75 <span type="species:ncbi:9598">chimpanzees</span>
Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study
###end article-title 98
###begin article-title 99
Understanding missense mutations in the BRCA1 gene: an evolutionary approach
###end article-title 99
###begin article-title 100
Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition
###end article-title 100
###begin article-title 101
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse
###end article-title 101
###begin article-title 102
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 42 52 <span type="species:ncbi:9598">chimpanzee</span>
Comparative genomic analysis of human and chimpanzee proteases
###end article-title 102
###begin article-title 103
Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms
###end article-title 103
###begin article-title 104
Similarities of prostate and breast cancer: Evolution, diet, and estrogens
###end article-title 104
###begin article-title 105
Diet and cancer--the European Prospective Investigation into Cancer and Nutrition
###end article-title 105
###begin article-title 106
###xml 32 37 <span type="species:ncbi:9606">human</span>
Chemical-induced DNA damage and human cancer risk
###end article-title 106
###begin article-title 107
###xml 57 63 <span type="species:ncbi:9606">humans</span>
Meat-adaptive genes and the evolution of slower aging in humans
###end article-title 107
###begin article-title 108
###xml 48 54 <span type="species:ncbi:9606">humans</span>
###xml 59 70 <span type="species:ncbi:9598">chimpanzees</span>
Differences in DNA methylation patterns between humans and chimpanzees
###end article-title 108
###begin article-title 109
Alterations of pre-mRNA splicing in cancer
###end article-title 109
###begin article-title 110
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
###end article-title 110
###begin article-title 111
Inflammation and cancer
###end article-title 111
###begin article-title 112
Cancer and the chemokine network
###end article-title 112
###begin article-title 113
Inflammation and necrosis promote tumour growth
###end article-title 113
###begin article-title 114
###xml 27 33 <span type="species:ncbi:9606">humans</span>
###xml 38 49 <span type="species:ncbi:9598">chimpanzees</span>
Evolution at two levels in humans and chimpanzees
###end article-title 114
###begin article-title 115
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Elevated gene expression levels distinguish human from non-human primate brains
###end article-title 115
###begin article-title 116
Intra- and interspecific variation in primate gene expression patterns
###end article-title 116
###begin article-title 117
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 50 60 <span type="species:ncbi:9598">chimpanzee</span>
Regional patterns of gene expression in human and chimpanzee brains
###end article-title 117
###begin article-title 118
###xml 133 139 <span type="species:ncbi:9606">humans</span>
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
###end article-title 118
###begin article-title 119
###xml 59 64 <span type="species:ncbi:9606">human</span>
Primary structure polymorphism at amino acid residue 72 of human p53
###end article-title 119
###begin article-title 120
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review
###end article-title 120
###begin article-title 121
The ink4a/arf locus evolution in primates: characterization of three ARF sequences
###end article-title 121
###begin article-title 122
Diversifying selection of the tumor-growth promoter angiogenin in primate evolution
###end article-title 122
###begin article-title 123
BLAT--the BLAST-like alignment tool
###end article-title 123
###begin article-title 124
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
###end article-title 124
###begin title 125
Figures and Tables
###end title 125
###begin p 126
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distribution of cancer genes in different functional categories</bold>
Distribution of cancer genes in different functional categories. The percentage of genes present in each category is indicated.
###end p 126
###begin p 127
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amino acid alignment of the p53 proline-rich domain from different primates</bold>
###xml 298 307 298 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 371 376 <span type="species:ncbi:9606">human</span>
Amino acid alignment of the p53 proline-rich domain from different primates. Schematic representation of p53 protein (AD: activator domain, PR: proline-rich domain; DB: DNA-binding domain; TD: tetramerization domain; and RD: C-terminal regulatory domain). The proline-rich domain containing Arg72 (arrowhead) was sequenced in different primate species and aligned to the human sequence.
###end p 127
###begin p 128
###xml 45 55 <span type="species:ncbi:9598">chimpanzee</span>
###xml 68 78 <span type="species:ncbi:9598">chimpanzee</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
Cancer genes with codons inserted/deleted in chimpanzee. Summary of chimpanzee cancer genes showing inserted/deleted codons with respect to the human sequence. The number of inserted/deleted codons, the amino acid change and whether the insertion/deletion occurred in trinucleotide expanded regions is shown. The status of this codon in human is also indicated.
###end p 128

